Previous 10 | Next 10 |
home / stock / cslly / cslly news
MAIDENHEAD, England, July 17, 2019 /PRNewswire/ -- CSL Limited today named Anjana Narain , a seasoned leader in vaccines and biopharmaceuticals, as Executive Vice President and General Manager of its Seqirus business, one of the world's largest influenza vaccines providers, effe...
SUMMIT, N.J. , July 15, 2019 /PRNewswire/ -- Seqirus is first to begin shipping its portfolio of seasonal influenza vaccines for the upcoming 2019/20 U.S. influenza season Seqirus plans to distribute more than 50 million doses of influenza vaccines to healthcare providers across the ...
How quickly things change!. In my May update , I commented that I was expecting the beginning of a more sustained pullback after a breathtaking start to 2019. Well, the market again surprised with a dramatic about turn. So much so that Project $1M clocked up a significant milestone and raced ...
Novel real world evidence for AFSTYLA® and IDELVION® to be highlighted MELBOURNE, Australia , July 2, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that the company will support the presentation of new data from its recombinant coagulation...
GENOA, Italy , June 20, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that it will support the presentation of eight scientific posters at the 2019 annual meeting of the Peripheral Nerve Society (PNS) , to be held 22-26 June, in Genoa, Italy . Res...
MARBURG, Germany , May 16, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the company has named five recipients of the 2019 Professor Heimburger Award for coagulation research. The global awards program demonstrates the company's contin...
BRAINTREE, Mass. and BOCA RATON, Fla. , May 14, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) and CSL Plasma Inc. today announced an agreement to transfer ownership of Haemonetics' Union, South Carolina , manufacturing facility, operating assets and certain inventories ...
KING OF PRUSSIA, Pa. , April 25, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring today announced that the US Food and Drug Administration (FDA) has approved 4- and 5-gram vial sizes for ZEMAIRA ® [Alpha 1 -Proteinase Inhibitor (Human)], its therapy for treat...
TOKYO , March 26, 2019 /PRNewswire/ -- Global biotherapeutics leader CSL Behring announced today that Japan's Ministry of Health, Labour and Welfare has approved two of its immunoglobulin therapies for the treatment of patients with chronic inflammatory demyelinating polyradiculo...
The steep correction of December 2018 now seems a distant memory. Project $1M made new all time highs in February as a result of renewed optimism on China and a swag of positive results from portfolio components. Overall, the portfolio finished up some 4.96% for the month, marginally outperf...
News, Short Squeeze, Breakout and More Instantly...
CSL Ltd ADR Company Name:
CSLLY Stock Symbol:
OTCMKTS Market:
Recently Published Real-World Evidence Study Shows Effectiveness of Cell-Based Quadrivalent Influenza Vaccine Over Three Seasons PR Newswire A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seas...
PHILADELPHIA, April 30, 2024 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with CSL, is bringing the only artificial intelligenc...
PHILADELPHIA, April 30, 2024 (GLOBE NEWSWIRE) -- The Mark Cuban Foundation, in partnership with CSL, is bringing the only artificial intelligence (AI) camp of its kind, free of charge, to high school students in Philadelphia. With a custom and highly-relevant curriculum focused on teaching studen...